CDK19 and AL amyloidosis: Recent studies have found that the overexpression and activation of CDK11 is crucial in the growth and proliferation of cancer cells, including breast cancer, multiple myeloma, osteosarcoma, and other types of cancer, which has suggested that CDK11 may be a novel potential therapeutic target [19–22].